Table of Contents
Chapter 1 Research Methodology
1.1 Market Segmentation and Scope
1.1.1 Segment Definitions
1.1.1.1 Test Segment
1.1.1.2 Service Provider Segment
1.1.1.3 Application Segment
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
1.4 Objectives
1.4.1 Objective – 1
1.4.2 Objective – 2
1.4.3 Objective – 3
1.5 Research Methodology
1.6 Information Procurement
1.6.1 Purchased Database
1.6.2 GVR’s Internal Database
1.6.3 Secondary Sources
1.6.4 Primary Research
1.7 Information or Data Analysis
1.7.1 Data Analysis Models
1.8 Market Formulation & Validation
1.9 Model Details
1.9.1 Commodity Flow Analysis
1.10 List of Secondary Sources
1.11 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Excipients Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Growing pharmaceutical market
3.1.1.2 Rising demand for novel excipients
3.1.1.3 Patent cliffs driving the growth of excipients in the generics market
3.1.2 Market restraint analysis
3.1.2.1 Stringent rules by regulatory bodies
3.2 Penetration & Growth Prospect Mapping for Products, 2022
3.3 Excipients Market – SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
Chapter 4 Excipients Market: Product Estimates & Trend Analysis
4.1 Global Excipients Market: Product Movement Analysis
4.2 Polymers
4.2.1 Global polymers market, 2018 – 2030 (USD Million, Tons)
4.2.2 Micro Crystalline Cellulose (MCC)
4.2.2.1 Global MCC market, 2018 – 2030 (USD Million, Tons)
4.2.3 Hydroxyl Propyl Methyl Cellulose (HPMC)
4.2.3.1 Global HPMC market, 2018 – 2030 (USD Million, Tons)
4.2.4 Ethyl cellulose
4.2.4.1 Global ethyl cellulose market, 2018 – 2030 (USD Million, Tons)
4.2.5 Methyl cellulose
4.2.5.1 Global methyl cellulose market, 2018 – 2030 (USD Million, Tons)
4.2.6 Carboxyl Methyl Cellulose (CMC)
4.2.6.1 Global CMC market, 2018 – 2030 (USD Million, Tons)
4.2.7 Croscarmellose sodium
4.2.7.1 Global croscarmellose sodium market, 2018 – 2030 (USD Million, Tons)
4.2.8 Povidone
4.2.8.1 Global povidone market, 2018 – 2030 (USD Million, Tons)
4.2.9 Pregelatinized starch
4.2.9.1 Global pregelatinized starch market, 2018 – 2030 (USD Million, Tons)
4.2.10 Sodium starch glycolate
4.2.10.1 Global sodium starch glycolate market, 2018 – 2030 (USD Million, Tons)
4.2.11 Polyethylene glycol
4.2.11.1 Global polyethylene glycol market, 2018 – 2030 (USD Million, Tons)
4.2.12 Acrylic polymers
4.2.12.1 Global acrylic polymers market, 2018 – 2030 (USD Million, Tons)
4.3 Alcohol
4.3.1 Global alcohol market, 2018 – 2030 (USD Million, Tons)
4.3.2 Glycerin
4.3.2.1 Global glycerin market, 2018 – 2030 (USD Million, Tons)
4.3.3 Propylene glycol
4.3.3.1 Global propylene glycol market, 2018 – 2030 (USD Million, Tons)
4.3.4 Sorbitol
4.3.4.1 Global sorbitol market, 2018 – 2030 (USD Million, Tons)
4.3.5 Mannitol
4.3.5.1 Global mannitol market, 2018 – 2030 (USD Million, Tons)
4.3.6 Others
4.3.6.1 Global other alcohol market, 2018 – 2030 (USD Million, Tons)
4.4 Minerals
4.4.1 Global minerals market, 2018 – 2030 (USD Million, Tons)
4.4.2 Calcium phosphate
4.4.2.1 Global calcium phosphate market, 2018 – 2030 (USD Million, Tons)
4.4.3 Calcium carbonate
4.4.3.1 Global calcium carbonate market, 2018 – 2030 (USD Million, Tons)
4.4.4 Clay
4.4.4.1 Global clay market, 2018 – 2030 (USD Million, Tons)
4.4.5 Silicon dioxide
4.4.5.1 Global silicon dioxide market, 2018 – 2030 (USD Million, Tons)
4.4.6 Titanium dioxide
4.4.6.1 Global titanium dioxide market, 2018 – 2030 (USD Million, Tons)
4.4.7 Others
4.4.7.1 Global other minerals market, 2018 – 2030 (USD Million, Tons)
4.5 Sugar & Others
4.5.1 Global sugar market, 2018 – 2030 (USD Million, Tons)
4.5.2 Lactose
4.5.2.1 Global lactose market, 2018 – 2030 (USD Million, Tons)
4.5.3 Sucrose
4.5.3.1 Global sucrose market, 2018 – 2030 (USD Million, Tons)
4.5.4 Others
4.5.4.1 Global other excipients market, 2018 – 2030 (USD Million, Tons)
4.6 Gelatin
4.6.1 Global gelatin market, 2018 – 2030 (USD Million, Tons)
Chapter 5 Excipients Market: Formulation Estimates & Trend Analysis
5.1 Global Excipients Market: Formulation Movement Analysis
5.2 Oral
5.2.1 Global oral market, 2018 – 2030 (USD Million)
5.3 Topical
5.3.1 Global topical market, 2018 – 2030 (USD Million)
5.4 Parenteral
5.4.1 Global parenteral market, 2018 – 2030 (USD Million)
5.5 Others
5.5.1 Global others market, 2018 – 2030 (USD Million)
Chapter 6 Excipients Market: Function Estimates & Trend Analysis
6.1 Global Excipients Market: Function Movement Analysis
6.2 Fillers and Diluents
6.2.1 Global fillers and diluents market, 2018 – 2030 (USD Million)
6.3 Suspending & Viscosity Agents
6.3.1 Global suspending & viscosity agents market, 2018 – 2030 (USD Million)
6.4 Coating Agents
6.4.1 Global coating agents market, 2018 – 2030 (USD Million)
6.5 Binders
6.5.1 Global binders market, 2018 – 2030 (USD Million)
6.6 Flavoring Agents & Sweeteners
6.6.1 Global flavoring agents & sweeteners market, 2018 – 2030 (USD Million)
6.7 Disintegrants
6.7.1 Global disintegrants agents market, 2018 – 2030 (USD Million)
6.8 Colorants
6.8.1 Global colorants market, 2018 – 2030 (USD Million)
6.9 Lubricants and Glidants
6.9.1 Global lubricants and glidants market, 2018 – 2030 (USD Million)
6.10 Preservatives
6.10.1 Global preservatives agents market, 2018 – 2030 (USD Million)
6.11 Emulsifying Agents
6.11.1 Global emulsifying agents market, 2018 – 2030 (USD Million)
6.12 Others
6.12.1 Global others and glidants market, 2018 – 2030 (USD Million)
Chapter 7 Excipients Market: Regional Estimates & Trend Analysis, by Product
7.1 Excipients Market: Regional Outlook
7.2 North America
7.2.1 North America Excipients Market Estimates And Forecasts, 2018 – 2030 (USD Million, Tons)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 U.S. Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.2.2.3 Target Disease Prevalence
7.2.2.5 Competitive Scenario
7.2.2.6 Regulatory Framework
7.2.2.7 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Key Country Dynamics
7.2.3.2 Canada Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.2.3.3 Target Disease Prevalence
7.2.3.4 Competitive Scenario
7.2.3.5 Regulatory Framework
7.2.3.6 Reimbursement Scenario
7.3 Europe
7.3.1 Europe Excipients Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.3.2 U.K.
7.3.2.1 Key Country Dynamics
7.3.2.2 U.K. Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.2.3 Target Disease Prevalence
7.3.2.4 Competitive Scenario
7.3.2.5 Regulatory Framework
7.3.2.6 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Key Country Dynamics
7.3.3.2 Germany Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.3.3 Target Disease Prevalence
7.3.3.4 Competitive Scenario
7.3.3.5 Regulatory Framework
7.3.3.6 Reimbursement Scenario
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 France Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.4.3 Target Disease Prevalence
7.3.4.4 Competitive Scenario
7.3.4.5 Regulatory Framework
7.3.4.6 Reimbursement Scenario
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Italy Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.5.3 Target Disease Prevalence
7.3.5.4 Competitive Scenario
7.3.5.5 Regulatory Framework
7.3.5.6 Reimbursement Scenario
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Spain Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.6.3 Target Disease Prevalence
7.3.6.4 Competitive Scenario
7.3.6.5 Regulatory Framework
7.3.6.6 Reimbursement Scenario
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Denmark Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.7.3 Target Disease Prevalence
7.3.7.4 Competitive Scenario
7.3.7.5 Regulatory Framework
7.3.7.6 Reimbursement Scenario
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Sweden Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.8.3 Target Disease Prevalence
7.3.8.4 Competitive Scenario
7.3.8.5 Regulatory Framework
7.3.8.6 Reimbursement Scenario
7.3.9 Norway
7.3.7.1 Key Country Dynamics
7.3.7.2 Norway Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.7.3 Target Disease Prevalence
7.3.7.4 Competitive Scenario
7.3.7.5 Regulatory Framework
7.3.7.6 Reimbursement Scenario
7.3.10 Russia
7.3.10.1 Key Country Dynamics
7.3.10.2 Russia Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.10.3 Target Disease Prevalence
7.3.10.4 Competitive Scenario
7.3.10.5 Regulatory Framework
7.3.10.6 Reimbursement Scenario
7.3.11 Netherlands
7.3.11.1 Key Country Dynamics
7.3.11.2 The Netherlands Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.3.11.3 Target Disease Prevalence
7.3.11.4 Competitive Scenario
7.3.11.5 Regulatory Framework
7.3.11.6 Reimbursement Scenario
7.4 Asia Pacific
7.4.1 Asia Pacific Excipients Market Estimates And Forecasts, 2018 – 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Japan Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.2.3 Target Disease Prevalence
7.4.2.4 Competitive Scenario
7.4.2.5 Regulatory Framework
7.4.2.6 Reimbursement Scenario
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 China Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.3.3 Target Disease Prevalence
7.4.3.4 Competitive Scenario
7.4.3.5 Regulatory Framework
7.4.3.6 Reimbursement Scenario
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 India Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.4.3 Target Disease Prevalence
7.4.4.4 Competitive Scenario
7.4.4.5 Regulatory Framework
7.4.4.6 Reimbursement Scenario
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Australia Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.5.3 Target Disease Prevalence
7.4.5.4 Competitive Scenario
7.4.5.5 Regulatory Framework
7.4.5.6 Reimbursement Scenario
7.4.6 South Korea
7.4.6.1 Key Country Dynamics
7.4.6.2 South Korea Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.6.3 Target Disease Prevalence
7.4.6.4 Competitive Scenario
7.4.6.5 Regulatory Framework
7.4.6.6 Reimbursement Scenario
7.4.7 Thailand
7.4.7.1 Key Country Dynamics
7.4.7.2 Thailand Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.7.3 Target Disease Prevalence
7.4.7.4 Competitive Scenario
7.4.7.5 Regulatory Framework
7.4.7.6 Reimbursement Scenario
7.4.8 Philippines
7.4.8.1 Key Country Dynamics
7.4.8.2 Philippines Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.8.3 Target Disease Prevalence
7.4.8.4 Competitive Scenario
7.4.8.5 Regulatory Framework
7.4.8.6 Reimbursement Scenario
7.4.9 Singapore
7.4.7.1 Key Country Dynamics
7.4.7.2 New Zealand Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.7.3 Target Disease Prevalence
7.4.7.4 Competitive Scenario
7.4.7.5 Regulatory Framework
7.4.7.6 Reimbursement Scenario
7.4.10 Malaysia
7.4.10.1 Key Country Dynamics
7.4.10.2 Philippines Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.10.3 Target Disease Prevalence
7.4.10.4 Competitive Scenario
7.4.10.5 Regulatory Framework
7.4.10.6 Reimbursement Scenario
7.4.11 New Zealand
7.4.11.1 Key Country Dynamics
7.4.11.2 Philippines Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.4.11.3 Target Disease Prevalence
7.4.11.4 Competitive Scenario
7.4.11.5 Regulatory Framework
7.4.11.6 Reimbursement Scenario
7.5 Latin America
7.5.1 Latin America Excipients Market Estimates And Forecasts, 2018 – 2030 (USD Million, Tons)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Brazil Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.5.2.3 Target Disease Prevalence
7.5.2.4 Competitive Scenario
7.5.2.5 Regulatory Framework
7.5.2.6 Reimbursement Scenario
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Mexico Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.5.3.3 Target Disease Prevalence
7.5.3.4 Competitive Scenario
7.5.3.5 Regulatory Framework
7.5.3.6 Reimbursement Scenario
7.5.4 Argentina
7.5.4.1 Key Country Dynamics
7.5.4.2 Argentina Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.5.4.3 Target Disease Prevalence
7.5.4.4 Competitive Scenario
7.5.4.5 Regulatory Framework
7.5.4.6 Reimbursement Scenario
7.6 Middle East and Africa
7.6.1 Middle East and Africa Excipients Market Estimates And Forecasts, 2018 – 2030 (USD Million, Tons)
7.6.1.1 Target Disease Prevalence
7.6.1.2 Competitive Scenario
7.6.1.3 Regulatory Framework
7.6.1.4 Reimbursement Scenario
7.6.2 South Africa
7.6.2.1 Key Country Dynamics
7.6.2.2 South Africa Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.6.2.3 Target Disease Prevalence
7.6.2.4 Competitive Scenario
7.6.2.5 Regulatory Framework
7.6.2.6 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Key Country Dynamics
7.6.3.2 Saudi Arabia Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.6.3.3 Target Disease Prevalence
7.6.3.4 Competitive Scenario
7.6.3.5 Regulatory Framework
7.6.3.6 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 Key Country Dynamics
7.6.4.2 UAE Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.6.4.3 Target Disease Prevalence
7.6.4.4 Competitive Scenario
7.6.4.5 Regulatory Framework
7.6.4.6 Reimbursement Scenario
7.6.5 KUWAIT
7.6.5.1 Key Country Dynamics
7.6.5.2 Kuwait Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.6.5.3 Target Disease Prevalence
7.6.5.4 Competitive Scenario
7.6.5.5 Regulatory Framework
7.6.5.6 Reimbursement Scenario
7.6.6 Israel
7.6.6.1 Key Country Dynamics
7.6.6.2 Israel Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.6.6.3 Target Disease Prevalence
7.6.6.4 Competitive Scenario
7.6.6.5 Regulatory Framework
7.6.6.6 Reimbursement Scenario
7.6.7 Turkey
7.6.7.1 Key Country Dynamics
7.6.7.2 Turkey Excipients Market Estimates & Forecasts And Trend Analysis, 2018 – 2030 (USD Million, Tons)
7.6.7.3 Target Disease Prevalence
7.6.7.4 Competitive Scenario
7.6.7.5 Regulatory Framework
7.6.7.6 Reimbursement Scenario
Chapter 8 Competitive Landscape
8.1 Company Categorization
8.2 Strategy Mapping
8.2.1 New Product Launch
8.2.2 Partnerships
8.2.3 Acquisition
8.2.4 Collaboration
8.2.5 Funding
8.3 Key Company Market Share Analysis, 2022
8.4 Company Profiles
8.4.1 Eastman Chemical Corporation
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.2 P&G
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.3 Avantor Performance Materials, LLC
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 Huntsman Corporation
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 BASF SE
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Ashland Inc.
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 FMC Corporation
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 Roquette
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.4 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Colorcon Inc.
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Lubrizol Corporation
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives
8.4.11 Valeant
8.4.11.1 Company overview
8.4.11.1.1 The Dow Chemical Company (Dow Pharma Solutions)
8.4.11.2 Financial performance
8.4.11.2.1 Financial performance
8.4.11.3 Product benchmarking
8.4.12 JRS PHARMA
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Product benchmarking
8.4.12.4 Strategic initiatives
8.4.13 Shin-Etsu Chemical Co., Ltd
8.4.13.1 Company overview
8.4.13.1.1 SE Pharma & Food Materials Distribution GmbH
8.4.13.2 Financial performance
8.4.13.3 Product benchmarking
8.4.13.4 Strategic initiatives
8.4.14 DFE pharma
8.4.14.1 Company overview
8.4.14.2 Financial performance
8.4.14.3 Product benchmarking
8.4.14.4 Strategic initiatives
8.4.15 FINAR LIMITED
8.4.15.1 Company overview
8.4.15.2 Financial performance
8.4.15.3 Product benchmarking
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer